| Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography N Papadopoulos, S Vasileiadi, M Papavdi, E Sveroni, P Antonakaki, ... Annals of gastroenterology 32 (5), 498, 2019 | 62 | 2019 |
| Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues N Papadopoulos, M Papavdi, A Pavlidou, D Konstantinou, H Kranidioti, ... Annals of gastroenterology 31 (3), 365, 2018 | 22 | 2018 |
| Long-term effect on health-related quality of life in patients with COVID-19 requiring hospitalization compared to non-hospitalized COVID-19 patients and healthy controls E Koullias, G Fragkiadakis, M Papavdi, G Manousopoulou, T Karamani, ... Cureus 14 (11), 2022 | 7 | 2022 |
| Pneumocystis jirovecii pneumonia after initiation of tofacitinib therapy in rheumatoid arthritis: case-based review I Grigoropoulos, K Thomas, P Christoforou, I Fanidi, M Papavdi, ... Mediterranean Journal of Rheumatology 30 (3), 167-170, 2019 | 7 | 2019 |
| The use of APRI and FIB-4 scores versus transient elastography (TE) for the assessment of liver fibrosis stage in patients with chronic hepatitis C (CHC): is it possible to … N Papadopoulos, S Vasileiadi, S Michalea, P Antonakaki, M Papavdi, ... Transfusion 269, 47, 2019 | 5 | 2019 |
| Sofosbuvir/Velpatasvir (SOF/VEL)+/-Ribavirin (RBV) in the Treatment of Genotype 3 (GT3) Chronic Hepatitis C (CHC) Patients. Heraclis: A Hellenic Multicenter Real-Life Cohort … S Manolakopoulos, V Sevastianos, K Triantafyllou, I Goulis, E Cholongitas, ... Hepatology 68, 378A-379A, 2018 | 2 | 2018 |
| CHANGES IN CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C (CHC) AND EFFECTIVENESS OF TREATMENT UPTAKE AFTER UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRALS (DAAS). A GREEK … S Vasileiadi, N Papadopoulos, P Antonakaki, M Papavdi, A Spanoudaki, ... Hepatology 70, 399A-399A, 2019 | 1 | 2019 |
| SAT-037-Applying the new nutritional screening and assessment algorithm to estimate malnutrition prevalence in Greek cirrhotic patients as suggested by the 2018 EASL … A Georgiou, G Papatheodoridis, A Alexopoulou, M Deutsch, ... Journal of Hepatology 70 (1), e642-e643, 2019 | 1 | 2019 |
| Addition of Dulaglutide or Empagliflozin to Standard-of-Care Treatment: Effect on Liver Steatosis in Patients With Type 2 Diabetes Mellitus E Koullias, M Papavdi, S Athanasopoulos, A Mitrakou, M Deutsch, ... Cureus 16 (2), 2024 | | 2024 |
| SUN-PO067: Prevalence of Malnutrition by GLIM Criteria and of Sarcopenia by the New Definition and Their Associations with 1-Year Survival in Cirrhotic Patients A Georgiou, G Papatheodoridis, M Deutsch, A Alexopoulou, ... Clinical Nutrition 38, S83-S84, 2019 | | 2019 |
| Evaluation of two nutrition screening tools in predicting malnutrition, sarcopenia and one-year survival In cirrhotic patients A Georgiou, G Papatheodoridis, M Deutsch, A Alexopoulou, ... Clinical Nutrition 37, S64, 2018 | | 2018 |
| Prevalence of malnutrition in a sample of cirrhotic patients A Georgiou, A Prapa, G Papatheodoridis, M Deutsch, A Alexopoulou, ... Clinical Nutrition 37, S63-S64, 2018 | | 2018 |
